间充质干细胞在肝脏的分化机制研究进展

doi:10.3969/j.issn.1672-5069.2010.03.035

摘要/Abstract

摘要： 间充质干细胞可通过旁分泌营养机制和分化为肝实质细胞等修复肝组织,移植间充质干细胞将成为临床治疗肝病的一种重要方法。本文介绍了间充质干细胞在微环境下,分化为肝实质细胞的可能机制以及影响其分化的相关因素。

林沪, 陈黎明, 王福生. 间充质干细胞在肝脏的分化机制研究进展[J]. 实用肝脏病杂志, 2010, 13(3): 238-239.

[1] KUO TK,HUNG SP,CHUANG CH,et a1. Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells[J]. Gastroenterology,2008,134（7）:2111-2121.
[2] DENG X,CHEN YX,ZHANG X,et al. Hepatic stellate cells modulate the differentiation of bone marrow mesenchymal stem cells into hepatocyte-like cells[J]. J Cell Physiol,2008,217（1）:138-144.
[3] OKUYAMA H,KRISHNAMACHARY B,ZHOU YF,et al. Expression of vascular endothelial growth factor receptor 1 in bone marrow-derived mesenchymal cells is dependent on hypoxia-inducible factor[J]. J Biol Chem,2006,281（22）:15554-15563.
[4] KÖHLER C,BELL AW,BOWEN WC,et al. Expression of Notch-1 and its ligand Jagged-1 in rat liver during liver regeneration[J]. Hepatology,2004,39(4):1056-1065.
[5] SHAFRITZ DA,OERTEL M,MENTHENA A,et al. Liver stem cells and prospects for liver reconstitution by transplanted cells[J]. Hepatology,2006,43（2 Suppl 1）:S89-98.
[6] AURICH H,SGODDA M,KALTWASSER P,et al. Hepatocyte differentiation of mesenchymal stem cells from human adipose tissue in vitro promotes hepatic integration in vivo[J]. Gut,2009,58(4):570-581.
[7] BONORA-CENTELLES A,JOVER R,MIRABET V,et al. Sequential hepatogenic trans-differentiation of adipose tissue-derived stem cells: relevance of different extracellular signaling molecules,transcription factors involved and expression of new key marker genes[J]. Cell Transplant,2009 Aug 5.
[8] CAMPARD D,LYSY PA,NAJIMI M,et al. Native umbilical cord matrix stem cells express hepatic markers and differentiate into hepatocyte-like cells[J]. Gastroenterology,2008,134（3）:833-848.
[9] BANAS A,TERATANI T,YAMAMOTO Y,et al. Rapid hepatic fate specification of adipose-derived stem cells and their therapeutic potential for liver failure[J]. J Gastroenterol Hepatol,2009,24（1）:70-77.
[10] ALVAREZ-DOLADO M,PARDAL R,GARCIA-VERDUGO JM,et al. Fusion of bone-marrow-derived cells with Purkinje neurons,cardiomyocytes and hepatocytes[J]. Nature,2003,425（6961）:968-973.
[11] FUJINO H,HIRAMATSU H,TSUCHIY A,et al. Human cord blood CD34+ cells develop into hepatocytes in the livers of NOD/SCID/gamma（c）null mice through cell fusion[J]. FASEB J,2007,21（13）:3499-3510.
[12] PISCAGLIA AC,NOVI M,CAMPANALE M,et al. Stem cell-based therapy in gastroenterology and hepatology[J]. Minim Invasive Ther Allied Technol,2008,17（2）:100-118.
[13] HARRIS RG,HERZOG EL,BRUSCIA EM,et al. Lack of fusion requirement for development of bone marrow-derived epithelia[J]. Science,2004,305（5680）:90-93.
[14] SATO Y,ARAKI H,KATO J,et al. Human mesenchymal stem cells xenografted directly to rat liver are differentiated into human hepatocytes without fusion[J]. Blood,2005,106（2）:756-763.
[15] SPAGGIARI GM,CAPOBIANCO A,ABDELRAZIK H,et a1. Mesenchymal stem cells inhibit natural killer cell proliferation,cytotoxicity and cytokine production:role of indoleamine 2,3-dioxygenase and prostaglandin E2[J]. Blood,2008,111（3）:1327-1333.
[16] KISS J,URBAN VS,DUDICS V,et al. Mesenchymal stem cells and the immune system-immunosuppression without drugs[J]. Orv Hetil,2008,149（8）:339-346.
[17] WANG Y,WEIL BR,HERRMANN JL,et al. MEK,p38 and PI-3K mediate cross talk between EGFR and TNFR in enhancing hepatocyte growth factor production from human mesenchymal stem cells[J]. Am J Physiol Cell Physiol,2009,Aug 19.
[18] WANG Y,WANG M,ABARBANELL AM,et al. MEK mediates the novel cross talk between TNFR2 and TGF-EGFR in enhancing vascular endothelial growth factor（VEGF）secretion from human mesenchymal stem cells[J]. Surgery,2009,146（2）:198-205.
[19] CRISOSTOMO PR,WANG Y,MARKEL TA,et al. Human mesenchymal stem cells stimulated by TNF-alpha, LPS,or hypoxia produce growth factors by an NF kappa B-but not JNK-dependent mechanism[J]. Am J Physiol Cell Physiol,2008,294（3）:C675-682.
[20] MOORE KA,LEMISCHKA IR. Stem cells and their niches[J]. Science,2006,311（5769）:1880-1885.
[21] SNYKERS S,VANHAECKE T,DE BECKER A,et al. Chromatin remodeling agent trichostatin A: a key-factor in the hepatic differentiation of human mesenchymal stem cells derived of adult bone marrow[J]. BMC Dev Biol,2007,7:24.
[22] CHIVU M,DIMA SO,STANCU CI,et al. In vitro hepatic differentiation of human bone marrow mesenchymal stem cells under differential exposure to liver-specific factors[J]. Transl Res,2009,154（3）:122-132.
[23] GU J,SHI X,ZHANG Y,et al. Heterotypic interactions in the preservation of morphology and functionality of porcine hepatocytes by bone marrow mesenchymal stem cells in vitro[J]. J Cell Physiol,2009,219（1）:100-108.
[24] SPEES JL,OLSON SD,YLOSTALO J,et al. Differentiation,cell fusion,and nuclear fusion during ex vivo repair of epithelium by human adult stem cells from bone marrow stroma[J]. Proc Natl Acad Sci USA,2003,100（5）:2397-2402.
[25] MASSON S,HARRISON DJ,PLEVRIS JN,et al. Potential of hematopoietic stem cell therapy in hepatology:a critical review[J]. Stem Cells,2004,22（6）: 897-907.
[26] ZHANG LY,CHEN X,XU SL,et al. Dose-dependent relationship of bone marrow mesenchymal stem cells transplantation to cardiomyogenesis for functional regenerative recovery after myocardial infarction[J]. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery,2007,6:447-452.

间充质干细胞在肝脏的分化机制研究进展

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	高磊, 曹蕾, 王瑞芳, 冯丹丹, 薛娟. 人脐带间充质干细胞移植对酒精性肝损伤大鼠的保护作用^*[J]. 实用肝脏病杂志, 2019, 22(6): 812-815.
[2]	朱赟, 姚根宏, 唐小军. 间充质干细胞移植干预2-OA/BSA诱导的原发性胆汁性胆管炎小鼠肝内胆管上皮细胞自噬蛋白表达的变化[J]. 实用肝脏病杂志, 2019, 22(3): 337-340.
[3]	张骏飞, 宋海燕, 陈曦, 潘劲劲, 刘力伟, 陈从新, 刘波. 多次人脐带间充质干细胞移植治疗失代偿期乙型肝炎肝硬化患者临床研究[J]. 实用肝脏病杂志, 2018, 21(5): 693-696.
[4]	赵宇, 祝瑜, 张代忠. 人脐带间充质干细胞肝内移植联合苦参素治疗失代偿期乙型肝炎肝硬化患者疗效与转归分析[J]. 实用肝脏病杂志, 2018, 21(3): 360-363.
[5]	张永婷, 朱传龙, 李军, 章莉莉. c-Met基因过表达脐带间充质干细胞株的构建*[J]. 实用肝脏病杂志, 2018, 21(3): 397-400.
[6]	焦栓林, 赵晓蕊, 欧阳洪, 杜世奇, 秦建增, 王全楚. 自体骨髓间充质干细胞联合促肝细胞生长素治疗失代偿期酒精性肝硬化疗效分析[J]. 实用肝脏病杂志, 2017, 20(6): 773-774.
[7]	文良志, 熊吉, 孙文静, 陈东风. 肝硬化与骨髓造血[J]. 实用肝脏病杂志, 2017, 20(4): 391-393.
[8]	孙文静, 刘凯军, 文良志, 陈东风. 骨髓间充质干细胞对肝脏的影响[J]. 实用肝脏病杂志, 2017, 20(4): 394-396.
[9]	周鸿, 顾磊, 蒋春晖, 孙隆慈, 刘晔, 许春杰, 徐庆. 1,25（OH）2D3通过STAT5抑制Th17细胞分化的调控作用研究^*[J]. 实用肝脏病杂志, 2016, 19(4): 404-407.
[10]	沈建坤，郑联坵，潘兴南，赖江琼. 自体骨髓间充质干细胞治疗失代偿期酒精性肝硬化疗效分析^*[J]. 实用肝脏病杂志, 2015, 18(6): 628-632.
[11]	吕胜祥，乔晓，梁凤，王昌成，别小芹，甘建和. 脐带间充质干细胞治疗自身免疫性肝病患者疗效观察^*[J]. 实用肝脏病杂志, 2015, 18(5): 500-503.
[12]	姜华, 高建鹏. 骨髓间充质干细胞治疗肝脏疾病研究进展[J]. 实用肝脏病杂志, 2015, 18(2): 217-220.
[13]	阮承兰, 陈从新. 间充质干细胞修复肝损伤的机制及膜微粒的生物治疗潜力^*[J]. 实用肝脏病杂志, 2015, 18(1): 97-100.
[14]	张志波,阮永华,高建鹏. Tregs/Th17和间充质干细胞在自身免疫性肝病的作用[J]. 实用肝脏病杂志, 2011, 14(5): 393-394.
[15]	魏开鹏,潘兴南,王崇国. 两种成人骨髓间充质干细胞体外分离方法的比较研究^*[J]. 实用肝脏病杂志, 2011, 14(2): 95-97.